CommercialCoverageMedium impact
06.02.54c, Cobalamin (Vitamin B12), Folic Acid, and Homocysteine Testing
Independence Blue Cross·Family Medicine, Internal Medicine, Endocrinology +2 more·Medical Policy
Effective date
Nov 26, 2025
We identified it
Jun 19, 2026
Summary
Independence Blue Cross has reissued their policy for Cobalamin (Vitamin B12), Folic Acid, and Homocysteine Testing effective November 26, 2025. This is a policy reissue for commercial plans, but specific changes to coverage criteria, prior authorization requirements, or billing procedures are not detailed in the summary provided.
Action Required
By November 26, 2025: Billing team must review the complete policy document at the provided URL to identify specific changes to coverage criteria, prior authorization requirements, or documentation needs for Vitamin B12, Folic Acid, and Homocysteine testing. Update billing procedures and staff training accordingly based on the full policy details.